Division of Nephrology, Boston Children's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA; Division of Nephrology and Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Kidney Int. 2021 Apr;99(4):828-840. doi: 10.1016/j.kint.2020.09.037. Epub 2020 Dec 8.
The kidney has extraordinary metabolic demands to sustain the active transport of solutes that is critical to renal filtration and clearance. Mitochondrial health is vital to meet those demands and maintain renal fitness. Decades of studies have linked poor mitochondrial health to kidney disease. Key regulators of mitochondrial health-adenosine monophosphate kinase, sirtuins, and peroxisome proliferator-activated receptor γ coactivator-1α-have all been shown to play significant roles in renal resilience against disease. This review will summarize the latest research into the activities of those regulators and evaluate the roles and therapeutic potential of targeting those regulators in acute kidney injury, glomerular kidney disease, and renal fibrosis.
肾脏具有非凡的代谢需求,以维持溶质的主动转运,这对肾脏过滤和清除至关重要。线粒体健康对于满足这些需求和维持肾脏健康至关重要。数十年来的研究将线粒体健康不良与肾脏疾病联系起来。线粒体健康的关键调节剂——腺苷单磷酸激酶、沉默调节蛋白和过氧化物酶体增殖物激活受体 γ 共激活因子 1α——都已被证明在肾脏对疾病的抵抗力中发挥着重要作用。本综述将总结这些调节剂活性的最新研究,并评估靶向这些调节剂在急性肾损伤、肾小球肾病和肾纤维化中的作用和治疗潜力。